2025 Breakthrough Bootcamp at BIO
Boston, MA 02108
Event summary
Cooley hosted this installment of Breakthrough Bootcamp, an invite-only event featuring panel discussions with insights and analysis from top business and legal minds in the life sciences industry.
Participants geared up for the second half of 2025 and beyond with strategic, business-driven insights from Cooley’s industry network.
Topics included:
- State of the Market – An overview of the financial landscape, covering key market trends for biotech companies, presented by Locust Walk.
- Speakers included Geoff Meyerson – CEO and co-founder at Locust Walk
- Resilient by Design: Supply Chain Innovations – Life sciences companies are designing their supply chains to build resilience, drive innovation and ensure continuity in an increasingly complex global landscape.
- Speakers included Christophe Beauduin (moderator) – Partner at Cooley; Sheila Ann Mikhail – Co-founder and executive chair at Jurata; Greg Scott – VP of global commercial strategy and operations at FUJIFILM Biotechnologies; and Luis Vilarin – Former general counsel for manufacturing, supply chain and EHS at Bristol Myers Squibb
- The New Money Map: Alternative Paths to Life Sciences Growth – What alternative financing strategies – from royalty deals and structured debt to public-private partnerships and strategic collaborations – are shaping the next wave of growth in life sciences?
- Speakers included James Schneider (moderator) – Partner at Cooley; Sandip Agarwala – Managing director and head of life sciences at Blue Owl Capital; Katie Bodner Spielberg – Principal at 5AM Ventures; Javeed Froozan – VP of business development and strategic alliances at the Leukemia & Lymphoma Society; and Shaan Gandhi – Head of strategic partnerships at Pfizer
- Build to Buy: Leveraging Structured Acquisitions – Thought leaders use research and development collaborations paired with acquisition options to fund and de-risk innovation.
- Speakers included Charity Williams (moderator) – Partner at Cooley; Brady Johnson – Senior VP of operations and finance at Tentarix Biotherapeutics; Jake Shuman – Head of transactions and M&A at Eli Lilly and Company; and Rama Padmanabhan – Partner at Cooley
At Cooley, we don’t just advise – we accelerate your achievements.
Our collaborative approach draws upon unparalleled experience and our extensive industry network to drive strategic solutions and resolve challenges.
With Cooley as your catalyst, you’re not just part of the life sciences industry – you’re shaping it.
Breakthroughs happen with Cooley.
Partnered with
For more information, please email life sciences marketing.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.